Verrica Pharmaceuticals
VRCA
VRCA
67 hedge funds and large institutions have $58.5M invested in Verrica Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
31% less capital invested
Capital invested by funds: $84.2M → $58.5M (-$25.8M)
88% less call options, than puts
Call options by funds: $16K | Put options by funds: $133K
Holders
67
Holding in Top 10
1
Calls
$16K
Puts
$133K
Top Buyers
| 1 | +$1.33M | |
| 2 | +$1.01M | |
| 3 | +$649K | |
| 4 |
Morgan Stanley
New York
|
+$277K |
| 5 |
BlackRock
New York
|
+$185K |
Top Sellers
| 1 | -$902K | |
| 2 | -$355K | |
| 3 | -$311K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$275K |
| 5 |
Two Sigma Advisers
New York
|
-$152K |